IL15 and cancer: Cancer cell death in the presence of either IL-15 alone or IL-15 in combination with ADU-S100 analog was observed (Figure 6), but to a less extent than described above (Figure 1): IL-15-pre-incubated PBMCs resulted in 5 and 12% of LNCaP and PC3 cell death, respectively.